A new CRISPR-based tool that is directly used on patients' cancer cells can identify genes and regulatory elements driving acute myeloid leukemia (AML), an aggressive blood cancer affecting the bone ...
HAELO Phase 3 clinical data for lonvo-z in HAE expected by mid-2026; BLA submission in second half of 2026; anticipated U.S. launch in first half ...
HAELO Phase 3 clinical data for lonvo-z in HAE expected by mid-2026; BLA submission in second half of 2026; anticipated U.S. launch in first half of 2027Process underway to reactivate global sites for ...
Vertex has continued to deliver breakthrough drugs for cystic fibrosis while exploring treatments for other illnesses ...
As Pioneer marks 100 years, leaders say gene editing and advanced data tools are poised to drive the next leap in corn yield, building on a century of gains from hybrids, biotech and management ...
Background Gut microbiota dysbiosis is linked to autism spectrum disorder (ASD) in children. However, the role of bacterial ...
A secondary stress signaling pathway in the response to optic axon injury is an unexpectedly strong contributor to both neurodegeneration and axon regenerative potential.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results